Wormiza 1000mg is a product containing fenbendazole, a benzimidazole antiparasitic compound. Fenbendazole is primarily used in veterinary medicine to manage certain parasitic worm infections in animals. Its approved uses, dosage, and safety information depend on the animal species and the specific product formulation.
It is important not to assume that a veterinary fenbendazole product is suitable for people. Current U.S. veterinary product information includes fenbendazole products with labels stating that they are not for human use.
For this reason, Wormiza 1000mg should not be presented as a general human deworming treatment unless there is appropriate regulatory approval and product-specific evidence supporting that use.
Fenbendazole belongs to the benzimidazole class of antiparasitic medicines. It acts against susceptible parasites by interfering with processes that are important for their survival, including energy metabolism and microtubule-related functions. This can prevent susceptible parasites from obtaining and using nutrients normally.
The exact effect depends on the parasite, animal species, formulation, and treatment regimen. It is therefore not appropriate to assume that the same dose or treatment schedule can be used across different species.
Fenbendazole Wormiza 1000 is used in veterinary medicine against certain susceptible parasitic worms. FDA-approved products containing fenbendazole have indications for particular parasites in specific animals.
For example, current FDA information lists fenbendazole products approved for cattle, goats, dogs, horses, and other animal uses depending on the formulation. The approved indication and dosage vary by product.
Common parasite groups associated with veterinary fenbendazole products may include:
The exact parasites covered depend on the veterinary product and animal species.
Fenbendazole Wormiza 1000 mg should be used according to the product label and the advice of a veterinarian when it is being used for an animal.
The appropriate amount is generally determined according to factors such as:
Do not transfer a veterinary dosage to humans or another animal species. Veterinary fenbendazole products can have species-specific directions and warnings. For example, some current product labels provide specific weight-based dosing instructions and state that the product is not intended for human use.
Fenbendazole should be used carefully and according to the approved product instructions. Veterinary products are formulated and evaluated for particular animal species and are not automatically appropriate for people.
The FDA has also reported adverse-event concerns associated with prolonged or extra-label fenbendazole use in dogs, including reports of bone marrow hypoplasia and pancytopenia.
This is one reason treatment should not be extended or modified without professional veterinary guidance.
The safety profile of fenbendazole can vary depending on the animal, formulation, dose, and duration of treatment.
If an animal develops unusual symptoms after receiving fenbendazole, contact a veterinarian for advice. Serious or unexpected reactions should receive prompt professional assessment.
Do not assume that a side-effect profile established for one animal species applies to humans or another species.
Before using a fenbendazole product for an animal, consider the following:
Fenbendazole should not be described as an FDA-approved human deworming medicine. FDA information identifies fenbendazole among veterinary drugs, while current veterinary labels may specifically state that certain products are not for use in humans.
People who believe they have a parasitic infection should speak with a qualified healthcare professional. The appropriate treatment depends on the specific parasite, diagnosis, medical history, and medicines approved for human use.
Fenbendazole is primarily used as a veterinary antiparasitic. A veterinary fenbendazole product should not be assumed to be suitable for human use. Some current product labels explicitly state that they are not for use in humans.
Fenbendazole is used in veterinary medicine to treat or control certain susceptible parasitic worms. Its approved use depends on the animal species and product formulation.
Do not give a veterinary fenbendazole product to a child. Human treatment for suspected parasitic infections should be selected by a qualified healthcare professional.
Potential interactions depend on the animal, medication, dosage, and treatment circumstances. A veterinarian should review other medicines before treatment.
For an animal receiving fenbendazole under veterinary guidance, follow the product label or contact the veterinarian for instructions rather than automatically doubling the next dose.
Wormiza 1000mg contains fenbendazole, an antiparasitic compound used in veterinary medicine against certain susceptible parasitic worms. Its appropriate use depends on the species, parasite, formulation, and approved treatment instructions.
Because veterinary medicines are not automatically appropriate for humans, Wormiza 1000mg should not be promoted as a human deworming treatment without appropriate regulatory evidence. Always check the product label and seek professional medical or veterinary advice when treatment is required.
| Pack Size | Price |
|---|---|
| 100 Tablet/s | $62.00 |
| 200 Tablet/s | $110.00 |
| 300 Tablet/s | $147.00 |
| 500 Tablet/s | $220.00 |
Medical Disclaimer: The information on this site is for educational purposes only. Consult a licensed healthcare professional before starting, stopping, or changing any medication.
Reviews
There are no reviews yet.